| Ytd | 25.36% | |
| 1y | 42.55% |
| Open | 5.94 | Prev Close | 5.94 | Low | 5.84 | High | 6.10 | Mkt Cap | 521.76M |
| Vol | 0.00 | Avg Vol | 1.20M | EPS | -0.21 | P/E | -28.42 | Forward P/E | N/A |
| Beta | 2.25 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 5.48 | 200-d Avg | 5.00 | 1yr Est | 0.00 |
SRTA News
Strata Critical Medical, Inc. (SRTA) shares have started gaining and might continue moving higher in
The consensus price target hints at a 60% upside potential for Strata Critical Medical, Inc. (SRTA).
Strata Critical Medical, Inc. (SRTA) Q2 2026 Earnings Call Transcript
Revenue increased 60.7% year-over-year to $72.5 million in Q2 2026 Clinical revenue increased 22.6%
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the
Strata Critical Medical is rated a buy, driven by expanding market share, operational efficiencies,
Network of experienced transplant surgeons in key markets will immediately become available to all S
Strata Critical Medical, Inc. (SRTA) was a big mover last session on higher-than-average trading vol
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or
Directors bring a strong combination of technology, healthcare, national security, leadership experi
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or
Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" o
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the
Ark Invest made no trades in its six main ETFs for two straight days, a rare feat. Here's how th
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” o
Strata Critical Medical is rated 'Buy' with a 12–24 month horizon, targeting 30–35% upside as valuat
Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript
Revenue increased 83.5% year-over-year to $66.8 million in Q4 2025 Logistics revenue and gross profi
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (Nasdaq: SRTA, “Strata” or the “
